AmP: AMAZING PRAGUE (PRAGUE-12)
Study Details
Study Description
Brief Summary
Aim of the project is to assess the long-time clinical impact of surgical ablation (MAZE procedure) on patients who suffer from atrial fibrillation but are indicated to a cardiac surgery for other predominant cardiac diagnosis (heart valve surgery, coronary revascularization or combined surgery). In recent years, those patients are more and more frequently indicated to some type of MAZE procedure, without the real benefit of this procedure for patients has been assessed with an enough large, randomized study. Even though it is well known, that MAZE procedures declines the early postoperative incidence of atrial fibrillation, convincing data about its mid-term and long-term impact on patients and about the appearance of recidives of atrial fibrillation in long-time horizon are still missing. Our hypothesis assumes, that MAZE procedure will significantly decrease the appearance of atrial fibrillation one year after the operation, without increasing mortality or incidence of serious postoperative complications in thirty postoperative days.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
A = MAZE Patients indicated to a cardiac surgery (bypass, valve repair or combinated surgery)with documented atrial fibrillation in 6 preoperative months undergo the operation together with MAZE procedure |
Procedure: Cox-MAZE III
Maze procedure according to standards of the department
|
B = non-MAZE Patients indicated to a cardiac surgery (bypass, valve repair or combinated surgery)with documented atrial fibrillation in 6 preoperative months undergo the operation (without MAZE procedure). |
Outcome Measures
Primary Outcome Measures
- presence of sinus rhythm [1 year after surgery]
- death, myocardial infarction, vascular cerebral attack, renal failure with a need of haemodyalisis [30 postoperative days]
Secondary Outcome Measures
- mortality, presence of sinus rhythm, serious complications- bleeding, vascular cerebral attack, heart failure, anticoagulation, anti-arrhytmics, pacemaker or ICD implantation, catether ablation... [1,3,5 months 1,5 years after surgery]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
indication to a cardiac surgery (coronary bypass, valve repair, others or combination of those)
-
atrial fibrillation (paroxysmal, persistent or permanent) present or documented in last 6 month before the operation
-
signed informed consent
Exclusion Criteria:
-
rejection of signing the informed consent with randomization
-
emergent surgery
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Cardiosurgery Department of University Hospital in Pilsen | Pilsen | Czech Republic | 305 99 | |
2 | Cardiocentre of Kralovske Vinohrady University Hospital | Prague | Czech Republic | 10034 | |
3 | Cardiology department of Masarykova Hospital Usti nad Labem | Usti nad Labem | Czech Republic | 40113 |
Sponsors and Collaborators
- Charles University, Czech Republic
Investigators
- Principal Investigator: Zbynek Straka, Prof.,MUDr.,CSc., Charles University, Prague
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 121402